Efficacy of Sofosbuvir and Daclatasvir in Patients With Fibrosing Cholestatic Hepatitis C After Liver Transplantation
Top Cited Papers
- 1 June 2015
- journal article
- clinical trial
- Published by Elsevier BV in Clinical Gastroenterology and Hepatology
- Vol. 13 (11), 1993-2001.e2
- https://doi.org/10.1016/j.cgh.2015.05.030
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Fibrosing Cholestatic Hepatitis in HIV/HCV Co-Infected Transplant Patients—Usefulness of Early Markers After Liver TransplantationAmerican Journal of Transplantation, 2011
- Clinical characterization of patients developing histologically‐proven fibrosing cholestatic hepatitis C post‐liver transplantationHepatology Research, 2011
- Post-liver transplant cholestatic hepatitis C: A systematic review of clinical and pathological findings and application of consensus criteriaLiver Transplantation, 2010
- Early histologic changes in fibrosing cholestatic hepatitis CLiver Transplantation, 2007
- Report of the First International Liver Transplantation Society Expert Panel Consensus Conference on liver transplantation and hepatitis CLiver Transplantation, 2003
- Retransplantation for recurrent hepatitis C: Positive aspectsLiver Transplantation, 2003
- Natural history of recurrent hepatitis CLiver Transplantation, 2002
- Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipientsJournal of Hepatology, 2002
- HEPATITIS C VIRUS-RELATED FIBROSING CHOLESTATIC HEPATITIS AFTER RENAL TRANSPLANTATIONTransplantation, 1997
- Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitisJournal of Hepatology, 1991